Steven Cohen’s GeneDx Holdings WGS Stock Holding History

Steven Cohen’s Portfolio WGS Stock Details WGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.41M	Buy	+64,200	New	+$3.65M	﹤0.01%	1847
2026 Q1	–	Sell	-2,000	Closed	-$260K	–	4589
2025 Q4	$260K	Buy	+2,000	New	+$275K	﹤0.01%	3535
2025 Q3	–	Sell	-70,000	Closed	-$6.46M	–	2731
2025 Q2	$6.46M	Buy	+70,000	New	+$5.5M	0.01%	886

Other funds holding WGS

Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Steven Cohen's WGS Position: Q2 2026 in Review

Steven Cohen increased its GeneDx Holdings (WGS) stake by 28% in Q2 2026, buying an estimated $1.22M and bringing the position to 97,300 shares worth $6.68M. The position accounts for 0.01% of the portfolio, ranked #1564.

Steven Cohen first reported a position in WGS in Q1 2024 and has held it in 8 quarters since. The position peaked at $25.4M in Q1 2025. 222 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

Steven Cohen held 97,300 shares of GeneDx Holdings worth $6.68M as of Q2 2026.
Steven Cohen bought 21,505 GeneDx Holdings shares in Q2 2026, an estimated $1.22M.
GeneDx Holdings made up 0.01% of Steven Cohen's portfolio in Q2 2026, its #1564 holding.
Steven Cohen first reported a position in GeneDx Holdings in Q1 2024 and has held it in 8 quarters since.
Steven Cohen's GeneDx Holdings position peaked at $25.4M in Q1 2025.
222 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.